Cargando…
Withaferin A ameliorates ovarian cancer-induced cachexia and proinflammatory signaling
BACKGROUND: Ovarian cancer is the fifth leading cause of cancer-related deaths amongst women in the United States. Cachexia is the primary cause of death in approximately 30% of cancer patients, and is often evidenced in ovarian cancer patients. We tested the steroidal lactone Withaferin A to examin...
Autores principales: | Straughn, Alex R., Kakar, Sham S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6878639/ https://www.ncbi.nlm.nih.gov/pubmed/31767036 http://dx.doi.org/10.1186/s13048-019-0586-1 |
Ejemplares similares
-
Withaferin A attenuates ovarian cancer-induced cardiac cachexia
por: Kelm, Natia Q., et al.
Publicado: (2020) -
Withaferin A and Ovarian Cancer Antagonistically Regulate Skeletal Muscle Mass
por: Straughn, Alex R., et al.
Publicado: (2021) -
Withaferin A: a potential therapeutic agent against COVID-19 infection
por: Straughn, Alex R., et al.
Publicado: (2020) -
Withaferin A Synergizes the Therapeutic Effect of Doxorubicin through ROS-Mediated Autophagy in Ovarian Cancer
por: Fong, Miranda Y., et al.
Publicado: (2012) -
Withaferin A (WFA) inhibits tumor growth and metastasis by targeting ovarian cancer stem cells
por: Kakar, Sham S., et al.
Publicado: (2017)